nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP2D6—Lomustine—brain cancer	0.156	0.218	CbGbCtD
Cyclobenzaprine—CYP1A2—Carmustine—brain cancer	0.154	0.216	CbGbCtD
Cyclobenzaprine—CYP2D6—Hydroxyurea—brain cancer	0.118	0.166	CbGbCtD
Cyclobenzaprine—CYP3A4—Temozolomide—brain cancer	0.116	0.163	CbGbCtD
Cyclobenzaprine—CYP3A4—Lomustine—brain cancer	0.099	0.139	CbGbCtD
Cyclobenzaprine—CYP1A2—Etoposide—brain cancer	0.0457	0.0641	CbGbCtD
Cyclobenzaprine—CYP3A4—Etoposide—brain cancer	0.0239	0.0336	CbGbCtD
Cyclobenzaprine—HTR2A—choroid plexus—brain cancer	0.0139	0.18	CbGeAlD
Cyclobenzaprine—HTR2A—trigeminal nerve—brain cancer	0.00703	0.0911	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellar cortex—brain cancer	0.007	0.0907	CbGeAlD
Cyclobenzaprine—HTR2A—vein—brain cancer	0.00635	0.0823	CbGeAlD
Cyclobenzaprine—HTR2A—cranial nerve—brain cancer	0.00501	0.0649	CbGeAlD
Cyclobenzaprine—HTR2A—pons—brain cancer	0.00495	0.0641	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalic ventricle—brain cancer	0.00407	0.0528	CbGeAlD
Cyclobenzaprine—HTR2A—pineal body—brain cancer	0.00353	0.0458	CbGeAlD
Cyclobenzaprine—HTR2A—ganglion—brain cancer	0.00253	0.0329	CbGeAlD
Cyclobenzaprine—HTR2A—endothelium—brain cancer	0.00219	0.0283	CbGeAlD
Cyclobenzaprine—HTR2A—blood vessel—brain cancer	0.00202	0.0261	CbGeAlD
Cyclobenzaprine—HTR2A—hindbrain—brain cancer	0.00192	0.0249	CbGeAlD
Cyclobenzaprine—CYP2D6—hindbrain—brain cancer	0.00175	0.0227	CbGeAlD
Cyclobenzaprine—Eosinophilia—Procarbazine—brain cancer	0.00132	0.00645	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Temozolomide—brain cancer	0.00132	0.00643	CcSEcCtD
Cyclobenzaprine—Leukopenia—Lomustine—brain cancer	0.00131	0.0064	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Temozolomide—brain cancer	0.00131	0.00639	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Procarbazine—brain cancer	0.00127	0.00619	CcSEcCtD
Cyclobenzaprine—Numbness—Etoposide—brain cancer	0.00124	0.00606	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Procarbazine—brain cancer	0.00123	0.00602	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Carmustine—brain cancer	0.00119	0.00581	CcSEcCtD
Cyclobenzaprine—Drowsiness—Procarbazine—brain cancer	0.00119	0.00581	CcSEcCtD
Cyclobenzaprine—Sensory loss—Etoposide—brain cancer	0.00119	0.0058	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Lomustine—brain cancer	0.00117	0.00571	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Procarbazine—brain cancer	0.00117	0.00569	CcSEcCtD
Cyclobenzaprine—Jaundice—Procarbazine—brain cancer	0.00116	0.00566	CcSEcCtD
Cyclobenzaprine—Stomatitis—Procarbazine—brain cancer	0.00116	0.00566	CcSEcCtD
Cyclobenzaprine—Mental disability—Carmustine—brain cancer	0.00116	0.00564	CcSEcCtD
Cyclobenzaprine—Face oedema—Hydroxyurea—brain cancer	0.00116	0.00563	CcSEcCtD
Cyclobenzaprine—Sweating—Procarbazine—brain cancer	0.00114	0.00557	CcSEcCtD
Cyclobenzaprine—Anorexia—Lomustine—brain cancer	0.00114	0.00556	CcSEcCtD
Cyclobenzaprine—Mental disability—Temozolomide—brain cancer	0.00112	0.00545	CcSEcCtD
Cyclobenzaprine—HTR2A—brainstem—brain cancer	0.0011	0.0143	CbGeAlD
Cyclobenzaprine—Hallucination—Procarbazine—brain cancer	0.00106	0.00519	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Temozolomide—brain cancer	0.00104	0.00509	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Lomustine—brain cancer	0.00104	0.00507	CcSEcCtD
Cyclobenzaprine—CYP2D6—brainstem—brain cancer	0.001	0.013	CbGeAlD
Cyclobenzaprine—Thirst—Temozolomide—brain cancer	0.000982	0.00479	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Hydroxyurea—brain cancer	0.000982	0.00479	CcSEcCtD
Cyclobenzaprine—HTR2A—telencephalon—brain cancer	0.000978	0.0127	CbGeAlD
Cyclobenzaprine—Purpura—Temozolomide—brain cancer	0.00097	0.00473	CcSEcCtD
Cyclobenzaprine—Diplopia—Carmustine—brain cancer	0.000967	0.00472	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Procarbazine—brain cancer	0.000955	0.00466	CcSEcCtD
Cyclobenzaprine—Alopecia—Procarbazine—brain cancer	0.000945	0.00461	CcSEcCtD
Cyclobenzaprine—Weight increased—Hydroxyurea—brain cancer	0.000941	0.00459	CcSEcCtD
Cyclobenzaprine—Diplopia—Temozolomide—brain cancer	0.000935	0.00456	CcSEcCtD
Cyclobenzaprine—Face oedema—Carmustine—brain cancer	0.000934	0.00455	CcSEcCtD
Cyclobenzaprine—Drowsiness—Hydroxyurea—brain cancer	0.000922	0.00449	CcSEcCtD
Cyclobenzaprine—Tension—Procarbazine—brain cancer	0.000914	0.00445	CcSEcCtD
Cyclobenzaprine—Ataxia—Carmustine—brain cancer	0.00091	0.00443	CcSEcCtD
Cyclobenzaprine—Nervousness—Procarbazine—brain cancer	0.000904	0.00441	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000904	0.00441	CcSEcCtD
Cyclobenzaprine—Face oedema—Temozolomide—brain cancer	0.000902	0.0044	CcSEcCtD
Cyclobenzaprine—Stomatitis—Hydroxyurea—brain cancer	0.000899	0.00438	CcSEcCtD
Cyclobenzaprine—CYP2D6—telencephalon—brain cancer	0.000891	0.0115	CbGeAlD
Cyclobenzaprine—Ataxia—Temozolomide—brain cancer	0.000879	0.00428	CcSEcCtD
Cyclobenzaprine—Tremor—Procarbazine—brain cancer	0.000872	0.00425	CcSEcCtD
Cyclobenzaprine—Syncope—Procarbazine—brain cancer	0.000835	0.00407	CcSEcCtD
Cyclobenzaprine—Leukopenia—Procarbazine—brain cancer	0.000833	0.00406	CcSEcCtD
Cyclobenzaprine—Hallucination—Hydroxyurea—brain cancer	0.000824	0.00401	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Procarbazine—brain cancer	0.000818	0.00399	CcSEcCtD
Cyclobenzaprine—HTR2A—gonad—brain cancer	0.000816	0.0106	CbGeAlD
Cyclobenzaprine—Convulsion—Procarbazine—brain cancer	0.000807	0.00393	CcSEcCtD
Cyclobenzaprine—Hypertension—Procarbazine—brain cancer	0.000804	0.00392	CcSEcCtD
Cyclobenzaprine—HTR2A—pituitary gland—brain cancer	0.000796	0.0103	CbGeAlD
Cyclobenzaprine—Pancytopenia—Carmustine—brain cancer	0.000794	0.00387	CcSEcCtD
Cyclobenzaprine—Myalgia—Procarbazine—brain cancer	0.000793	0.00386	CcSEcCtD
Cyclobenzaprine—Anxiety—Procarbazine—brain cancer	0.00079	0.00385	CcSEcCtD
Cyclobenzaprine—CYP1A2—endocrine gland—brain cancer	0.000789	0.0102	CbGeAlD
Cyclobenzaprine—Dry mouth—Procarbazine—brain cancer	0.000775	0.00378	CcSEcCtD
Cyclobenzaprine—HTR2A—medulla oblongata—brain cancer	0.000768	0.00996	CbGeAlD
Cyclobenzaprine—Pancytopenia—Temozolomide—brain cancer	0.000767	0.00374	CcSEcCtD
Cyclobenzaprine—Confusional state—Procarbazine—brain cancer	0.000766	0.00373	CcSEcCtD
Cyclobenzaprine—Vomiting—Lomustine—brain cancer	0.000761	0.00371	CcSEcCtD
Cyclobenzaprine—Oedema—Procarbazine—brain cancer	0.00076	0.0037	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000751	0.00366	CcSEcCtD
Cyclobenzaprine—Shock—Procarbazine—brain cancer	0.000748	0.00364	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Temozolomide—brain cancer	0.000746	0.00364	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Temozolomide—brain cancer	0.000744	0.00363	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Procarbazine—brain cancer	0.000744	0.00363	CcSEcCtD
Cyclobenzaprine—Tachycardia—Procarbazine—brain cancer	0.000742	0.00362	CcSEcCtD
Cyclobenzaprine—Weight increased—Temozolomide—brain cancer	0.000735	0.00358	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Procarbazine—brain cancer	0.000735	0.00358	CcSEcCtD
Cyclobenzaprine—Alopecia—Hydroxyurea—brain cancer	0.000731	0.00357	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Carmustine—brain cancer	0.000731	0.00356	CcSEcCtD
Cyclobenzaprine—Stomatitis—Carmustine—brain cancer	0.000727	0.00354	CcSEcCtD
Cyclobenzaprine—Anorexia—Procarbazine—brain cancer	0.000724	0.00353	CcSEcCtD
Cyclobenzaprine—Nausea—Lomustine—brain cancer	0.000711	0.00347	CcSEcCtD
Cyclobenzaprine—Hypotension—Procarbazine—brain cancer	0.00071	0.00346	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Temozolomide—brain cancer	0.000706	0.00344	CcSEcCtD
Cyclobenzaprine—HTR2A—midbrain—brain cancer	0.000702	0.0091	CbGeAlD
Cyclobenzaprine—Stomatitis—Temozolomide—brain cancer	0.000702	0.00342	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000692	0.00337	CcSEcCtD
Cyclobenzaprine—Insomnia—Procarbazine—brain cancer	0.000687	0.00335	CcSEcCtD
Cyclobenzaprine—HTR2A—spinal cord—brain cancer	0.000685	0.00888	CbGeAlD
Cyclobenzaprine—Paraesthesia—Procarbazine—brain cancer	0.000682	0.00333	CcSEcCtD
Cyclobenzaprine—Somnolence—Procarbazine—brain cancer	0.000676	0.00329	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000669	0.00326	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Carmustine—brain cancer	0.000666	0.00325	CcSEcCtD
Cyclobenzaprine—Hallucination—Carmustine—brain cancer	0.000666	0.00325	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Procarbazine—brain cancer	0.000661	0.00322	CcSEcCtD
Cyclobenzaprine—Carbamazepine—CYP2C9—brain cancer	0.000657	0.129	CrCbGaD
Cyclobenzaprine—Fatigue—Procarbazine—brain cancer	0.000655	0.00319	CcSEcCtD
Cyclobenzaprine—Malaise—Hydroxyurea—brain cancer	0.00065	0.00317	CcSEcCtD
Cyclobenzaprine—Constipation—Procarbazine—brain cancer	0.00065	0.00317	CcSEcCtD
Cyclobenzaprine—Hepatitis—Temozolomide—brain cancer	0.000647	0.00315	CcSEcCtD
Cyclobenzaprine—Leukopenia—Hydroxyurea—brain cancer	0.000645	0.00314	CcSEcCtD
Cyclobenzaprine—Hallucination—Temozolomide—brain cancer	0.000643	0.00314	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Temozolomide—brain cancer	0.000643	0.00314	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Temozolomide—brain cancer	0.000642	0.00313	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Procarbazine—brain cancer	0.000626	0.00305	CcSEcCtD
Cyclobenzaprine—Convulsion—Hydroxyurea—brain cancer	0.000624	0.00304	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Procarbazine—brain cancer	0.000621	0.00303	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ESR2—brain cancer	0.00062	0.122	CrCbGaD
Cyclobenzaprine—HTR2A—endocrine gland—brain cancer	0.000617	0.00799	CbGeAlD
Cyclobenzaprine—Pancytopenia—Etoposide—brain cancer	0.000614	0.00299	CcSEcCtD
Cyclobenzaprine—HTR2A—head—brain cancer	0.000609	0.00789	CbGeAlD
Cyclobenzaprine—Discomfort—Hydroxyurea—brain cancer	0.000606	0.00295	CcSEcCtD
Cyclobenzaprine—Urticaria—Procarbazine—brain cancer	0.000604	0.00294	CcSEcCtD
Cyclobenzaprine—Tinnitus—Temozolomide—brain cancer	0.000603	0.00294	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Procarbazine—brain cancer	0.000601	0.00293	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Carmustine—brain cancer	0.000598	0.00291	CcSEcCtD
Cyclobenzaprine—Alopecia—Carmustine—brain cancer	0.000591	0.00288	CcSEcCtD
Cyclobenzaprine—Oedema—Hydroxyurea—brain cancer	0.000588	0.00287	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000576	0.00281	CcSEcCtD
Cyclobenzaprine—Alopecia—Temozolomide—brain cancer	0.000571	0.00279	CcSEcCtD
Cyclobenzaprine—CYP3A4—endocrine gland—brain cancer	0.000571	0.0074	CbGeAlD
Cyclobenzaprine—Acute coronary syndrome—Etoposide—brain cancer	0.000568	0.00277	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Etoposide—brain cancer	0.000565	0.00275	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Etoposide—brain cancer	0.000565	0.00275	CcSEcCtD
Cyclobenzaprine—CYP2D6—endocrine gland—brain cancer	0.000562	0.00728	CbGeAlD
Cyclobenzaprine—Stomatitis—Etoposide—brain cancer	0.000562	0.00274	CcSEcCtD
Cyclobenzaprine—Jaundice—Etoposide—brain cancer	0.000562	0.00274	CcSEcCtD
Cyclobenzaprine—Anorexia—Hydroxyurea—brain cancer	0.000561	0.00273	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Procarbazine—brain cancer	0.00056	0.00273	CcSEcCtD
Cyclobenzaprine—HTR2A—central nervous system—brain cancer	0.000556	0.0072	CbGeAlD
Cyclobenzaprine—CYP2D6—head—brain cancer	0.000555	0.00719	CbGeAlD
Cyclobenzaprine—Dysgeusia—Temozolomide—brain cancer	0.000551	0.00269	CcSEcCtD
Cyclobenzaprine—Vision blurred—Carmustine—brain cancer	0.000549	0.00268	CcSEcCtD
Cyclobenzaprine—Tremor—Carmustine—brain cancer	0.000546	0.00266	CcSEcCtD
Cyclobenzaprine—Asthenia—Procarbazine—brain cancer	0.000545	0.00266	CcSEcCtD
Cyclobenzaprine—HTR2A—cerebellum—brain cancer	0.000543	0.00704	CbGeAlD
Cyclobenzaprine—Nortriptyline—CYP2C9—brain cancer	0.000541	0.106	CrCbGaD
Cyclobenzaprine—Agranulocytosis—Etoposide—brain cancer	0.000538	0.00262	CcSEcCtD
Cyclobenzaprine—Pruritus—Procarbazine—brain cancer	0.000538	0.00262	CcSEcCtD
Cyclobenzaprine—Agitation—Carmustine—brain cancer	0.000535	0.00261	CcSEcCtD
Cyclobenzaprine—Vision blurred—Temozolomide—brain cancer	0.000531	0.00259	CcSEcCtD
Cyclobenzaprine—Tremor—Temozolomide—brain cancer	0.000527	0.00257	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Hydroxyurea—brain cancer	0.000524	0.00256	CcSEcCtD
Cyclobenzaprine—Somnolence—Hydroxyurea—brain cancer	0.000523	0.00255	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Temozolomide—brain cancer	0.000522	0.00255	CcSEcCtD
Cyclobenzaprine—Leukopenia—Carmustine—brain cancer	0.000521	0.00254	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Procarbazine—brain cancer	0.00052	0.00253	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Hydroxyurea—brain cancer	0.000518	0.00252	CcSEcCtD
Cyclobenzaprine—Agitation—Temozolomide—brain cancer	0.000517	0.00252	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Etoposide—brain cancer	0.000515	0.00251	CcSEcCtD
Cyclobenzaprine—CYP3A4—central nervous system—brain cancer	0.000515	0.00667	CbGeAlD
Cyclobenzaprine—Angioedema—Temozolomide—brain cancer	0.000514	0.00251	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Hydroxyurea—brain cancer	0.000511	0.00249	CcSEcCtD
Cyclobenzaprine—Trimipramine—CYP2C9—brain cancer	0.000509	0.0999	CrCbGaD
Cyclobenzaprine—Malaise—Temozolomide—brain cancer	0.000508	0.00247	CcSEcCtD
Cyclobenzaprine—Fatigue—Hydroxyurea—brain cancer	0.000507	0.00247	CcSEcCtD
Cyclobenzaprine—CYP2D6—central nervous system—brain cancer	0.000506	0.00656	CbGeAlD
Cyclobenzaprine—Vertigo—Temozolomide—brain cancer	0.000506	0.00247	CcSEcCtD
Cyclobenzaprine—Convulsion—Carmustine—brain cancer	0.000505	0.00246	CcSEcCtD
Cyclobenzaprine—Leukopenia—Temozolomide—brain cancer	0.000504	0.00246	CcSEcCtD
Cyclobenzaprine—Hypertension—Carmustine—brain cancer	0.000503	0.00245	CcSEcCtD
Cyclobenzaprine—Constipation—Hydroxyurea—brain cancer	0.000503	0.00245	CcSEcCtD
Cyclobenzaprine—Dizziness—Procarbazine—brain cancer	0.000502	0.00245	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—CYP2C9—brain cancer	0.0005	0.0981	CrCbGaD
Cyclobenzaprine—Palpitations—Temozolomide—brain cancer	0.000497	0.00243	CcSEcCtD
Cyclobenzaprine—Myalgia—Carmustine—brain cancer	0.000496	0.00242	CcSEcCtD
Cyclobenzaprine—Chest pain—Carmustine—brain cancer	0.000496	0.00242	CcSEcCtD
Cyclobenzaprine—CYP2D6—cerebellum—brain cancer	0.000495	0.00641	CbGeAlD
Cyclobenzaprine—Anxiety—Carmustine—brain cancer	0.000494	0.00241	CcSEcCtD
Cyclobenzaprine—Promethazine—CYP2C9—brain cancer	0.00049	0.0962	CrCbGaD
Cyclobenzaprine—Convulsion—Temozolomide—brain cancer	0.000488	0.00238	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP2C9—brain cancer	0.000487	0.0955	CrCbGaD
Cyclobenzaprine—Hypertension—Temozolomide—brain cancer	0.000486	0.00237	CcSEcCtD
Cyclobenzaprine—Doxepin—CYP2C9—brain cancer	0.000485	0.0952	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Hydroxyurea—brain cancer	0.000485	0.00236	CcSEcCtD
Cyclobenzaprine—Vomiting—Procarbazine—brain cancer	0.000483	0.00236	CcSEcCtD
Cyclobenzaprine—Confusional state—Carmustine—brain cancer	0.000479	0.00234	CcSEcCtD
Cyclobenzaprine—Myalgia—Temozolomide—brain cancer	0.000479	0.00234	CcSEcCtD
Cyclobenzaprine—Rash—Procarbazine—brain cancer	0.000479	0.00234	CcSEcCtD
Cyclobenzaprine—Dermatitis—Procarbazine—brain cancer	0.000479	0.00233	CcSEcCtD
Cyclobenzaprine—Anxiety—Temozolomide—brain cancer	0.000478	0.00233	CcSEcCtD
Cyclobenzaprine—Headache—Procarbazine—brain cancer	0.000476	0.00232	CcSEcCtD
Cyclobenzaprine—Oedema—Carmustine—brain cancer	0.000475	0.00232	CcSEcCtD
Cyclobenzaprine—Discomfort—Temozolomide—brain cancer	0.000474	0.00231	CcSEcCtD
Cyclobenzaprine—Dry mouth—Temozolomide—brain cancer	0.000469	0.00228	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Carmustine—brain cancer	0.000465	0.00227	CcSEcCtD
Cyclobenzaprine—Tachycardia—Carmustine—brain cancer	0.000464	0.00226	CcSEcCtD
Cyclobenzaprine—Confusional state—Temozolomide—brain cancer	0.000463	0.00226	CcSEcCtD
Cyclobenzaprine—Oedema—Temozolomide—brain cancer	0.000459	0.00224	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Temozolomide—brain cancer	0.000459	0.00224	CcSEcCtD
Cyclobenzaprine—Alopecia—Etoposide—brain cancer	0.000457	0.00223	CcSEcCtD
Cyclobenzaprine—Anorexia—Carmustine—brain cancer	0.000453	0.00221	CcSEcCtD
Cyclobenzaprine—Nausea—Procarbazine—brain cancer	0.000451	0.0022	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Temozolomide—brain cancer	0.00045	0.00219	CcSEcCtD
Cyclobenzaprine—Hypotension—Carmustine—brain cancer	0.000444	0.00217	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Temozolomide—brain cancer	0.000444	0.00217	CcSEcCtD
Cyclobenzaprine—HTR2A—brain—brain cancer	0.000441	0.00572	CbGeAlD
Cyclobenzaprine—Dysgeusia—Etoposide—brain cancer	0.000441	0.00215	CcSEcCtD
Cyclobenzaprine—Anorexia—Temozolomide—brain cancer	0.000438	0.00213	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Hydroxyurea—brain cancer	0.000433	0.00211	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000433	0.00211	CcSEcCtD
Cyclobenzaprine—Promazine—CYP2C9—brain cancer	0.000431	0.0846	CrCbGaD
Cyclobenzaprine—Insomnia—Carmustine—brain cancer	0.00043	0.0021	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Carmustine—brain cancer	0.000427	0.00208	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Carmustine—brain cancer	0.000424	0.00207	CcSEcCtD
Cyclobenzaprine—Somnolence—Carmustine—brain cancer	0.000423	0.00206	CcSEcCtD
Cyclobenzaprine—Asthenia—Hydroxyurea—brain cancer	0.000422	0.00206	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000419	0.00204	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Etoposide—brain cancer	0.000418	0.00204	CcSEcCtD
Cyclobenzaprine—Insomnia—Temozolomide—brain cancer	0.000416	0.00203	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Carmustine—brain cancer	0.000413	0.00201	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Temozolomide—brain cancer	0.000413	0.00201	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Temozolomide—brain cancer	0.00041	0.002	CcSEcCtD
Cyclobenzaprine—Somnolence—Temozolomide—brain cancer	0.000408	0.00199	CcSEcCtD
Cyclobenzaprine—Constipation—Carmustine—brain cancer	0.000407	0.00198	CcSEcCtD
Cyclobenzaprine—Malaise—Etoposide—brain cancer	0.000406	0.00198	CcSEcCtD
Cyclobenzaprine—Vertigo—Etoposide—brain cancer	0.000405	0.00197	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Temozolomide—brain cancer	0.000404	0.00197	CcSEcCtD
Cyclobenzaprine—Leukopenia—Etoposide—brain cancer	0.000403	0.00197	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Hydroxyurea—brain cancer	0.000402	0.00196	CcSEcCtD
Cyclobenzaprine—CYP2D6—brain—brain cancer	0.000402	0.00521	CbGeAlD
Cyclobenzaprine—Decreased appetite—Temozolomide—brain cancer	0.000399	0.00195	CcSEcCtD
Cyclobenzaprine—Fatigue—Temozolomide—brain cancer	0.000396	0.00193	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Etoposide—brain cancer	0.000396	0.00193	CcSEcCtD
Cyclobenzaprine—Constipation—Temozolomide—brain cancer	0.000393	0.00192	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Carmustine—brain cancer	0.000392	0.00191	CcSEcCtD
Cyclobenzaprine—Convulsion—Etoposide—brain cancer	0.00039	0.0019	CcSEcCtD
Cyclobenzaprine—Hypertension—Etoposide—brain cancer	0.000389	0.0019	CcSEcCtD
Cyclobenzaprine—Dizziness—Hydroxyurea—brain cancer	0.000389	0.0019	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Carmustine—brain cancer	0.000389	0.0019	CcSEcCtD
Cyclobenzaprine—Chest pain—Etoposide—brain cancer	0.000383	0.00187	CcSEcCtD
Cyclobenzaprine—Discomfort—Etoposide—brain cancer	0.000379	0.00185	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Temozolomide—brain cancer	0.000379	0.00185	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Carmustine—brain cancer	0.000376	0.00183	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Temozolomide—brain cancer	0.000376	0.00183	CcSEcCtD
Cyclobenzaprine—Amitriptyline—CYP2C9—brain cancer	0.000375	0.0736	CrCbGaD
Cyclobenzaprine—Vomiting—Hydroxyurea—brain cancer	0.000374	0.00182	CcSEcCtD
Cyclobenzaprine—Rash—Hydroxyurea—brain cancer	0.000371	0.00181	CcSEcCtD
Cyclobenzaprine—Confusional state—Etoposide—brain cancer	0.000371	0.00181	CcSEcCtD
Cyclobenzaprine—Dermatitis—Hydroxyurea—brain cancer	0.00037	0.00181	CcSEcCtD
Cyclobenzaprine—Headache—Hydroxyurea—brain cancer	0.000368	0.0018	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Etoposide—brain cancer	0.000368	0.00179	CcSEcCtD
Cyclobenzaprine—Urticaria—Temozolomide—brain cancer	0.000365	0.00178	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Temozolomide—brain cancer	0.000363	0.00177	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Etoposide—brain cancer	0.00036	0.00175	CcSEcCtD
Cyclobenzaprine—Tachycardia—Etoposide—brain cancer	0.000359	0.00175	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Etoposide—brain cancer	0.000355	0.00173	CcSEcCtD
Cyclobenzaprine—Anorexia—Etoposide—brain cancer	0.00035	0.00171	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Carmustine—brain cancer	0.00035	0.00171	CcSEcCtD
Cyclobenzaprine—Nausea—Hydroxyurea—brain cancer	0.000349	0.0017	CcSEcCtD
Cyclobenzaprine—Hypotension—Etoposide—brain cancer	0.000344	0.00167	CcSEcCtD
Cyclobenzaprine—Asthenia—Carmustine—brain cancer	0.000341	0.00166	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Temozolomide—brain cancer	0.000338	0.00165	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Etoposide—brain cancer	0.00033	0.00161	CcSEcCtD
Cyclobenzaprine—Asthenia—Temozolomide—brain cancer	0.00033	0.00161	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Etoposide—brain cancer	0.000328	0.0016	CcSEcCtD
Cyclobenzaprine—Somnolence—Etoposide—brain cancer	0.000327	0.00159	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Carmustine—brain cancer	0.000325	0.00159	CcSEcCtD
Cyclobenzaprine—Pruritus—Temozolomide—brain cancer	0.000325	0.00158	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Etoposide—brain cancer	0.00032	0.00156	CcSEcCtD
Cyclobenzaprine—Fatigue—Etoposide—brain cancer	0.000317	0.00155	CcSEcCtD
Cyclobenzaprine—Dizziness—Carmustine—brain cancer	0.000314	0.00153	CcSEcCtD
Cyclobenzaprine—Constipation—Etoposide—brain cancer	0.000314	0.00153	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Temozolomide—brain cancer	0.000314	0.00153	CcSEcCtD
Cyclobenzaprine—Dizziness—Temozolomide—brain cancer	0.000304	0.00148	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Etoposide—brain cancer	0.000303	0.00148	CcSEcCtD
Cyclobenzaprine—Vomiting—Carmustine—brain cancer	0.000302	0.00147	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Etoposide—brain cancer	0.000301	0.00147	CcSEcCtD
Cyclobenzaprine—Rash—Carmustine—brain cancer	0.0003	0.00146	CcSEcCtD
Cyclobenzaprine—Dermatitis—Carmustine—brain cancer	0.000299	0.00146	CcSEcCtD
Cyclobenzaprine—Headache—Carmustine—brain cancer	0.000298	0.00145	CcSEcCtD
Cyclobenzaprine—Vomiting—Temozolomide—brain cancer	0.000292	0.00142	CcSEcCtD
Cyclobenzaprine—Urticaria—Etoposide—brain cancer	0.000292	0.00142	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Etoposide—brain cancer	0.000291	0.00142	CcSEcCtD
Cyclobenzaprine—Rash—Temozolomide—brain cancer	0.00029	0.00141	CcSEcCtD
Cyclobenzaprine—Dermatitis—Temozolomide—brain cancer	0.000289	0.00141	CcSEcCtD
Cyclobenzaprine—Headache—Temozolomide—brain cancer	0.000288	0.0014	CcSEcCtD
Cyclobenzaprine—Nausea—Carmustine—brain cancer	0.000282	0.00138	CcSEcCtD
Cyclobenzaprine—Nausea—Temozolomide—brain cancer	0.000273	0.00133	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Etoposide—brain cancer	0.000271	0.00132	CcSEcCtD
Cyclobenzaprine—Asthenia—Etoposide—brain cancer	0.000264	0.00129	CcSEcCtD
Cyclobenzaprine—Pruritus—Etoposide—brain cancer	0.00026	0.00127	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Etoposide—brain cancer	0.000252	0.00123	CcSEcCtD
Cyclobenzaprine—Dizziness—Etoposide—brain cancer	0.000243	0.00119	CcSEcCtD
Cyclobenzaprine—Vomiting—Etoposide—brain cancer	0.000234	0.00114	CcSEcCtD
Cyclobenzaprine—Rash—Etoposide—brain cancer	0.000232	0.00113	CcSEcCtD
Cyclobenzaprine—Dermatitis—Etoposide—brain cancer	0.000232	0.00113	CcSEcCtD
Cyclobenzaprine—Headache—Etoposide—brain cancer	0.00023	0.00112	CcSEcCtD
Cyclobenzaprine—Nausea—Etoposide—brain cancer	0.000218	0.00106	CcSEcCtD
